Loading provider…
Loading provider…
Neurology Physician in Orange, CA
NPI: 1730276825Primary Practice Location
UNIVERSITY OF CALIFORNIA IRVINE MEDICAL CENTER
101 The City Dr S, Orange, CA
Primary Employer
Regents of the University of Claifornia Univ Neursciences
ucihealth.org
HQ Phone
Get MD, PHD Claire's Phone Numberphone_androidMobile
Get MD, PHD Claire's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
NY State Medical License
CA State Medical License
2020 - 2026
NY State Medical License
1998 - 2021

American Board of Psychiatry and Neurology
Neurology
New York Presbyterian Hospital (Cornell Campus)
Fellowship • Neuromuscular Medicine (Neurology)
2001 - 2003
Residency • Neurology
1998 - 2001
Residency • Internal Medicine
1997 - 1998
University of California, Berkeley
Post-Doctoral Fellowship • 1989 - 1992
1989 - 1992
University of Oxford, Sir William Dunn School of Pathology
Molecular/Cell Biology
1985 - 1988
University of Oxford, Keble College
BA • Biochemistry
1981 - 1985
Vagelos College of Physicians and Surgeons
vagelos.columbia.edu
Medical School
Until 1997
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 54 | 103 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 25 | 32 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 15 | 15 |
Authors: Viviane Tabar
Journal: Cell Stem Cell
Biomarkers of Parkinson's disease and Dementia with Lewy bodies.
Authors: Andersson, M, Zetterberg, H, Minthon, L, Blennow, K, Londos, E
Journal: Int J Geriatr Psychiatry
NEURON DEATH IN THE SUBSTANTIA NIGRA OF WEAVER MOUSE OCCURS LATE IN DEVELOPMENT AND IS NOT APOPTOTIC
Authors: Oo, T F, Blazeski, R, Harrison, S M, Henchcliffe, C, Mason, C A, Roffler-Tarlov, S K, Burke, R E
Journal: J Neurosci
Lead Sponsor: University of Texas Southwestern Medical Center
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS), Yale University, Purdue University
Lead Sponsor: Prevail Therapeutics
Collaborators: Eli Lilly and Company
Intervention / Treatment: DRUG: Sirolimus, DRUG: Methylprednisolone, BIOLOGICAL: LY3884961
Lead Sponsor: InSightec
Intervention / Treatment: DEVICE: Blood Brain Barrier (BBB) Disruption